289 related articles for article (PubMed ID: 25312013)
1. Evidence for peripheral immune activation in amyotrophic lateral sclerosis.
Chen X; Feng W; Huang R; Guo X; Chen Y; Zheng Z; Shang H
J Neurol Sci; 2014 Dec; 347(1-2):90-5. PubMed ID: 25312013
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.
Murdock BJ; Zhou T; Kashlan SR; Little RJ; Goutman SA; Feldman EL
JAMA Neurol; 2017 Dec; 74(12):1446-1454. PubMed ID: 28973548
[TBL] [Abstract][Full Text] [Related]
3. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.
Saleh IA; Zesiewicz T; Xie Y; Sullivan KL; Miller AM; Kuzmin-Nichols N; Sanberg PR; Garbuzova-Davis S
J Neuroimmunol; 2009 Oct; 215(1-2):96-101. PubMed ID: 19682755
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate.
Shi N; Kawano Y; Tateishi T; Kikuchi H; Osoegawa M; Ohyagi Y; Kira J
J Neuroimmunol; 2007 Jan; 182(1-2):232-5. PubMed ID: 17097743
[TBL] [Abstract][Full Text] [Related]
6. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).
Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Hadlock K; Jin X; Reis J; Narvaez A; McGrath MS
J Neuroimmunol; 2005 Feb; 159(1-2):215-24. PubMed ID: 15652422
[TBL] [Abstract][Full Text] [Related]
7. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
8. Mirror movements in amyotrophic lateral sclerosis.
Wittstock M; Meister S; Walter U; Benecke R; Wolters A
Amyotroph Lateral Scler; 2011 Nov; 12(6):393-7. PubMed ID: 21554031
[TBL] [Abstract][Full Text] [Related]
9. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
10. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity in Guamanians with amyotrophic lateral sclerosis and parkinsonism-dementia.
Hoffman PM; Robbins DS; Oldstone MB; Gibbs CJ; Gajdusek DC
Ann Neurol; 1981 Aug; 10(2):193-6. PubMed ID: 7283404
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
13. Humoral factors in ALS patients during disease progression.
Ehrhart J; Smith AJ; Kuzmin-Nichols N; Zesiewicz TA; Jahan I; Shytle RD; Kim SH; Sanberg CD; Vu TH; Gooch CL; Sanberg PR; Garbuzova-Davis S
J Neuroinflammation; 2015 Jun; 12():127. PubMed ID: 26126965
[TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis.
Çoban A; Ulusoy C; Giriş M; Turan S; Türkoğlu R; Tüzün E; Idrisoğlu HA
Int J Neurosci; 2013 Aug; 123(8):557-62. PubMed ID: 23461588
[TBL] [Abstract][Full Text] [Related]
16. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
17. The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood.
Roozendaal B; Kim S; Wolf OT; Kim MS; Sung KK; Lee S
Psychoneuroendocrinology; 2012 Jan; 37(1):20-6. PubMed ID: 21616601
[TBL] [Abstract][Full Text] [Related]
18. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
[TBL] [Abstract][Full Text] [Related]
19. The R of ALSFRS-R: does it really mirror functional respiratory involvement in amyotrophic lateral sclerosis?
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):120-3. PubMed ID: 25205208
[TBL] [Abstract][Full Text] [Related]
20. Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis.
Henriques A; Blasco H; Fleury MC; Corcia P; Echaniz-Laguna A; Robelin L; Rudolf G; Lequeu T; Bergaentzle M; Gachet C; Pradat PF; Marchioni E; Andres CR; Tranchant C; Gonzalez De Aguilar JL; Loeffler JP
PLoS One; 2015; 10(7):e0131512. PubMed ID: 26147510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
